AlzeCure Pharmas

AlzeCure Pharma AB is a Swedish pharmaceutical company with a primary focus on Alzheimer’s disease. AlzeCure Pharma is developing five drug candidates within its two main research programs, NeuroRestore och Alzstatin.

BioReperia AB

BioReperia has developed a unique zebrafish technology platform for evaluating efficacy and toxicity for your substances. Our models enable you to select the leads that have highest potential to success as drug candidates.

BioThema AB

BioThema is entirely focused on analytical applications of the firefly luciferase reaction. This reaction can be used for assays of number of cells, cell proliferation and cytotoxicity, all enzymes and metabolites participating in ATP forming or degrading reactions, reporter gene assays, immunoassays, rapid cell counting and hygiene control.

Novandi Chemistry AB

Novandi Chemistry offers a comprehensive carbon-14, tritium and stable isotope labeling service and acts as a hub for regulatory and non-regulatory studies with radiolabeled compounds and drug candidates. The company offers customers a long-term responsibility for radioactive labeled substances through storage and continuous quality control.

Redoxis

Redoxis performs tailor-made preclinical studies combining dedication, experience and agility to provide reliable results to your project.